The FDA's Fast Track Designation for the Experimental Gonorrhea Vaccine

FDA's fast tracking GSK, Glaxo Smith Klein for those who are unaware of the initials experimental gonorrhea vaccine got a fast track designation from the US regulators. The shot is in position to become the first preventative for a common, often undetected infection that's gaining resistance and treatment.